Northwestern Events Calendar

Nov
9
2022

Marco Colonna, MD - Center for Human Immunobiology Distinguished Lectureship Series "Myeloid cells in neurodegeneration and cancer"

When: Wednesday, November 9, 2022
3:30 PM - 4:30 PM CT

Where: Simpson Querrey Biomedical Research Center, Simpson-Querrey Auditorium, 303 E. Superior Street, Chicago, IL 60611 map it

Audience: Faculty/Staff - Student - Post Docs/Docs - Graduate Students

Contact: Lisa Rawlani  

Group: Center for Human Immunobiology (CHI)

Category: Lectures & Meetings

Description:

Guest Speaker Information:

Marco Colonna, MD
Washington University School of Medicine in St. Louis


Robert Rock Belliveau, MD Professor of Pathology and Immunology

Dr. Marco Colonna was born in Parma, Italy, received his medical degree and specialization in internal medicine at Parma University (Parma, Italy) and completed his postdoctoral training at Harvard Medical School (Cambridge, Massachusetts, USA). He became a scientific member of the Basel Institute for Immunology (Basel, Switzerland). Since 2001 he has been a Professor of Pathology & Immunology at Washington University School of Medicine in St. Louis, MO, USA. Since 2019 Dr. Colonna is a member of the National Academy of Science. Dr. Colonna’s research focuses on immunoreceptors. In this field his accomplishments encompass identification and characterization of the Killer cell Ig-like receptors and HLA-C polymorphisms as their inhibitory ligands, as well as the discovery of the LILR and TREM inhibitory and activating receptor families. Through analysis of the cellular distribution of these receptors, he identified plasmacytoid dendritic cells as source of IFN-/ in anti-viral responses and innate lymphoid cells that produce IL-22 in mucosae. His current areas of research include: 1) Innate lymphoid cells in mucosal immunity. 2) Plasmacytoid dendritic cells in host defense and autoimmunity.3) TREM2 and innate immunoreceptors in Alzheimer’s disease and cancer.

Register Add to Calendar

Add Event To My Group:

Please sign-in